Perry de Jongh

Perry de Jongh serves as the Executive Director of Clinical Research Services at ICON plc since July 2021, following a role in the same capacity at PRA Health Sciences from January 2020 to July 2021. Prior experience includes serving as the Global Head of Clinical Development at medac GmbH, where responsibilities encompassed all clinical phase I - IIIb studies. Perry held the position of Medical Director at Lundbeck, overseeing Medical Affairs, Medical Information, Regulatory Affairs, and Pharmacovigilance for Central Europe, and previously served as Medical Director and Head of Development at Grünenthal Group, managing a range of medical and clinical activities. Early in the career, Perry worked as International Clinical Development Manager at Bayer Pharmaceuticals, focusing on clinical development for CNS drugs. Perry earned a Medical Doctor degree from Erasmus University Rotterdam between 1980 and 1987.